The Relationship of Body Mass Index to Outcomes after Percutaneous Coronary Intervention
- 4 October 2006
- journal article
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 19 (5) , 388-395
- https://doi.org/10.1111/j.1540-8183.2006.00189.x
Abstract
Objectives: To evaluate the effect of body mass index (BMI) on in‐hospital outcomes in patients undergoing percutaneous coronary intervention (PCI) at a tertiary care hospital center in Ontario, Canada. Background: Obesity is present in a large population of patients undergoing revascularization with PCI. Methods: Retrospective analysis of 4,631 patients aged 62.0 ± 12 years, stratified by BMI into five groups: nonobese (2); overweight (25–29.9 kg/m2); class I obese (30–34.9 kg/m2); class II obese (35–39.9 kg/m2); and class III obese (≥40 kg/m2). Results: A BMI >25 kg/m2 was present in 79% of patients, and 35% were obese (BMI ≥30 kg/m2). Obese patients, particularly the class III obese, were significantly younger and had higher prevalence of diabetes, hypertension, and dyslipidemia (P < 0.0001). After adjustment for several covariates, lower BMI was independently associated with higher risk of major bleeding requiring transfusion (adjusted odds ratio [OR]= 1.40, 95% confidence interval [CI] 1.04–1.88, P = 0.025), and femoral hematoma (adjusted OR = 1.14, 95% CI 1.05–1.25, P = 0.003) in lean (2) and normal BMI (20–24.9 kg/m2) patients. Obesity was not associated with death, myocardial infarction, repeat PCI, coronary artery bypass grafting, or major adverse cardiac event. Conclusions: Obesity is not associated with increased risk of adverse postprocedural in‐hospital outcomes. These findings, however, do not discount the need for sustained efforts in secondary prevention of obesity and its consequences.Keywords
This publication has 20 references indexed in Scilit:
- Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devicesJournal of the American College of Cardiology, 2005
- Relationship Between Activated Clotting Time and Ischemic or Hemorrhagic ComplicationsCirculation, 2004
- Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventionsThe American Journal of Cardiology, 2004
- Obesity and cardiovascular riskGrowth Hormone & IGF Research, 2003
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionJAMA, 2003
- Heparin dose during percutaneous coronary intervention: how low dare we go?Heart, 2002
- The impact of obesity on the short-term andlong-term outcomes after percutaneous coronary intervention: the obesity paradox?Published by Elsevier ,2002
- Hypothesis: β-Adrenergic Receptor Blockers and Weight GainHypertension, 2001
- Body-Mass Index and Mortality in a Prospective Cohort of U.S. AdultsNew England Journal of Medicine, 1999
- Low-Normal or Excessive Body Mass Index: Newly Identified and Powerful Risk Factors for Death and Other Complications With Percutaneous Coronary InterventionThe American Journal of Cardiology, 1996